State Of Wisconsin Investment Board Mirati Therapeutics, Inc. Transaction History

State Of Wisconsin Investment Board

$36.3 Billion
Q1 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	SELL	$41.99 - $62.38 $67,225 - $99,870	-1,601 Reduced 4.56%	33,503 $1.97 Million
Q3 2023 Nov 14, 2023	SELL	$27.8 - $45.35 $4,170 - $6,802	-150 Reduced 0.43%	35,104 $1.53 Million
Q2 2023 Aug 14, 2023	SELL	$36.13 - $49.49 $201,063 - $275,411	-5,565 Reduced 13.63%	35,254 $1.27 Million
Q1 2023 May 15, 2023	BUY	$36.54 - $54.26 $104,723 - $155,509	2,866 Added 7.55%	40,819 $1.52 Million
Q4 2022 Feb 14, 2023	SELL	$41.27 - $98.62 $68,136 - $162,821	-1,651 Reduced 4.17%	37,953 $1.72 Million

Q3 2022 Nov 14, 2022	SELL	$59.5 - $86.7 $136,850 - $199,410	-2,300 Reduced 5.49%	39,604 $2.77 Million
Q2 2022 Aug 15, 2022	BUY	$39.16 - $88.71 $276,156 - $625,582	7,052 Added 20.23%	41,904 $2.81 Million
Q1 2022 May 13, 2022	BUY	$75.82 - $150.97 $1.22 Million - $2.44 Million	16,141 Added 86.26%	34,852 $2.87 Million
Q4 2021 Feb 11, 2022	BUY	$132.01 - $190.29 $22,969 - $33,110	174 Added 0.94%	18,711 $2.75 Million
Q3 2021 Nov 12, 2021	BUY	$132.13 - $177.45 $30,654 - $41,168	232 Added 1.27%	18,537 $3.28 Million
Q2 2021 Aug 12, 2021	SELL	$144.0 - $179.73 $7.62 Million - $9.51 Million	-52,913 Reduced 74.3%	18,305 $2.96 Million
Q1 2021 May 17, 2021	SELL	$158.92 - $221.61 $3.16 Million - $4.41 Million	-19,905 Reduced 21.84%	71,218 $12.2 Million
Q4 2020 Feb 03, 2021	BUY	$162.05 - $240.27 $2.03 Million - $3.01 Million	12,517 Added 15.92%	91,123 $20 Million
Q2 2020 Aug 12, 2020	BUY	$72.01 - $120.39 $936,130 - $1.57 Million	13,000 Added 19.82%	78,606 $8.97 Million
Q1 2020 May 06, 2020	BUY	$69.78 - $116.21 $857,945 - $1.43 Million	12,295 Added 23.06%	65,606 $5.04 Million
Q4 2019 Feb 14, 2020	BUY	$70.76 - $128.86 $1.13 Million - $2.05 Million	15,911 Added 42.54%	53,311 $6.87 Million
Q3 2019 Nov 12, 2019	BUY	$77.91 - $109.6 $490,833 - $690,480	6,300 Added 20.26%	37,400 $2.91 Million
Q2 2019 Aug 14, 2019	BUY	$59.49 - $104.71 $208,215 - $366,485	3,500 Added 12.68%	31,100 $3.2 Million
Q1 2019 May 13, 2019	BUY	$43.65 - $78.95 $301,185 - $544,755	6,900 Added 33.33%	27,600 $2.02 Million
Q4 2018 Feb 11, 2019	BUY	$32.0 - $47.43 $73,600 - $109,089	2,300 Added 12.5%	20,700 $878,000
Q2 2018 Aug 03, 2018	BUY	$26.05 - $52.4 $479,320 - $964,160	18,400 New	18,400 $907,000

Others Institutions Holding MRTX

# of Institutions

Shares Held

3.57M

Call Options Held

Put Options Held

36.6K

View Full List

About Mirati Therapeutics, Inc.

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

More about MRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wisconsin Investment Board with notifications on news.

Account